Exploring the links between specific depression symptoms and brain structure: a network study by Hilland, E. et al.
Japan
Email: hayashit@otsuka.jp
Received 19 December 2019; revised 22 December 2019;
accepted 23 December 2019.
Exploring the links between
specific depression symptoms
and brain structure: A network
study
doi:10.1111/pcn.12969
Various patterns of structural brain abnormalities have been associated
with depression, yet sensitive, specific and clinically predictive brain cor-
relates have proven to be difficult to characterize.1 The currently best
available empirical evidence on neuroanatomical differences between
patients with major depression (MDD) and healthy controls are two meta-
analyses of approximately 10 000 individuals.2,3 These reports show
widespread alterations in cortical regions and in hippocampal volume, but
no associations between depression severity and brain structure. Inconsis-
tencies in the neuroimaging literature may be explained by the fact that
depression is highly heterogeneous, featuring over 50 symptoms,4 where
symptom constellations may reflect different phenomena with distinct
underlying biological causes.1
Understanding the neural substrates of specific symptoms may pro-
vide important information about mechanisms underlying depression vul-
nerability. A growing body of research under the umbrella term ‘network
approach’ has recently received considerable attention5; the approach
understands and aims to model mental disorders as systems of causally
interacting symptoms. So far, network studies have been based on symp-
toms and environmental factors, ignoring relevant neurobiological fac-
tors.6 Here, we address this knowledge gap by modeling a joint network
of depression-related brain structures and individual depression symp-
toms, using 21 symptoms and five regional brain measures. The sample is
a mixed group of individuals that previously have been treated for one or
more major depressive episodes (MDE) and never depressed individuals,
with the goal to model a continuum of depression severity.
Depression symptoms were measured using the Beck Depression
Inventory (BDI-II). MRI images were obtained from a 3T Philips scanner.
Whole-brain volumetric segmentation and cortical surface reconstruction
of MRI images was performed with FreeSurfer 5.3 (https://surfer.nmr.
mgh.harvard.edu/). Five regional brain measures were selected based on
the MDD case-control differences showing the largest bilateral effects in
the studies from the ENIGMA MMD working group2,3: hippocampal vol-
ume and cortical thickness in four regions - medial orbitofrontal cortex
(mOFC), fusiform gyrus, insula and cingulate (weighted average of rostral
anterior cingulate, caudal anterior cingulate and posterior cingulate).
Brain structure measures were averaged across the left and right hemi-
sphere for each participant, and z-residuals of hippocampal volume (con-
trolling for sex and estimated intracranial volume) were calculated for































Fusiform gyrus – Hippocampus
mOFC – Fusiform gyrus
Hippocampus – Changes in appetite
Insula – Loss of intrerest in sex
Cingulate – Sadness
Hippocampus – Sadness
Hippocampus – Loss of interest
Hippocampus – Irritability
Fusiform gyrus – Crying
Cingulate – Crying
Fusiform gyrus – Irritability
Cingulate – Worthlessness
Insula – Sadness
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Fig.1 (a) Depression symptom network including five brain areas. Blue lines represent positive associations, red lines negative associations, and the thickness and
brightness of an edge indicate the association strength. AGIT, agitation; ANHED, loss of pleasure; APPET, changes in appetite; CINGULATE, rostral-, medial-, and
anterior cingulate cortex; CONC, concentration difficulty; CRITIC, self-criticism; CRY, crying; DISL, self-dislike; ENER, loss of energy; FAIL, past failure; FATIG, tired-
ness or fatigue; FUSIFORM, fusiform gyrus; GUILT, guilty feelings; HIPPOCAMP, hippocampus; INDECISIVE, indecisiveness; INSULA, insula; INTER, loss of interest;
IRRIT, irritability; mOFC, medial orbitofrontal cortex; PESS, pessimism; PUNISH, punishment feelings; SAD, sadness; SEX, loss of interest in sex; SLEEP, changes in
sleep pattern; SUIC, suicidal thoughts or wishes; WORTH, worthlessness. (b) Sparse partial correlations between brain structure measures, and between brain struc-
ture measures and depressive symptoms in the network model.
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computed using the R packages qgraph and bootnet, and the graphical
LASSO (least absolute shrinkage and selection operator) was used for
regularization (see Appendix S1 for details on MRI acquisition, MRI
processing and network analysis).
This sample was drawn from two related clinical trials and a case-
control research study conducted at the Department of Psychology, Uni-
versity of Oslo. Informed consent was obtained from all participants
before enrolment and their anonymity was preserved. The sample consists
of 268 adult participants, 191 with at least one MDE [M age = 39.4
(SD = 13.2), 132 females, M education level (ISCED) level 6.0
(SD = 0.9), M BDI-II score 14.7 (SD = 10.4)] and 77 never depressed
individuals [M age = 41.9 (SD = 12.9), M education level 5.7 (SD = 1.5),
M BDI-II score 1.7 (SD = 2.9), 50 females]. BDI-II sum score range was
0–49. A total of 172 subjects had experienced two or more MDE’s. Sixty-
one participants were currently using antidepressant medication.
The symptom-brain network is depicted in Figure 1a,b. All brain
structures were positively inter-connected, with regularized partial correla-
tions up to 0.40. Hippocampus was associated with changes in appetite
sadness, loss of interest and irritability. Insula was associated with loss of
interest in sex and sadness. Cingulate had associations with sadness, cry-
ing and worthlessness. Fusiform gyrus had associations with crying and
irritability (see stability and centrality indices, Figures S1 and S2).
Here we establish the first link between individual depression symp-
toms and neuroanatomy using network analysis. Our results broadly align
with prior literature showing that depression symptoms differentially
relate to important outcomes such as impairment and risk factors, and
demonstrate the importance of studying specific features of depression
over one heterogeneous category.5,6 The associations between symptoms
and brain structure may reflect the heterogeneous nature of the disorder,
and may offer important cues about underlying neural mechanisms in
MDD. The results await replication in larger samples and other patient
groups. In this study depression history was assessed retrospectively and
previous MDE was classified independent of type of treatment, combina-
tion treatment, treatment response or time since the last episode. We hope
the reported results can pave the way for future studies integrating neuro-
biological measures in network analyses, which represent a step toward
validation of biomarkers.
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Approximately 20% of schizophrenic patients have associated
polydipsia,1 and they account for 80% of polydipsia patients. Once poly-
dipsia proceeds to water intoxication, increased impulsivity often brings
them seclusion and prolonged hospitalization. Schizophrenic patients are
reported to have a shortened lifespan, and it is even shorter when they
have comorbid polydipsia.2 Medications for polydipsia have not been
identified but are urgently needed to promote deinstitutionalization and an
improved life prognosis. We found only one report on topiramate,3 and
additional verification is necessary. We describe a case in which
topiramate was effective for polydipsia of treatment-resistant schizophre-
nia, with submission approval of an Institutional Review Board after the
treatment. The patient and her sister gave us a signed release, and patient
anonymity has been secured.
A 57-year-old woman was hospitalized for the 25th time because of
delusions, auditory hallucinations, and violent behaviors. She was diagnosed
with schizophrenia and mild mental retardation (full-scale IQ of 61 on the
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